Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2025-12-25 @ 12:22 AM
NCT ID: NCT03590158
Eligibility Criteria: Inclusion Criteria: * Waist circumference ≥94 cm * Weight-stable (\< 5 % fluctuation in their body weight for past 6-months at study entry) Exclusion Criteria: * Personal history and/or diagnosis of: diabetes, cancer, major psychiatric disorders, liver disease, gastro-intestinal surgery or disease (including malabsorption), eating disorders, anaemia, insomnia, cardiovascular disease deemed unstable by the study physician. * use of prescribed or non-prescribed medications which may affect energy metabolism, gastrointestinal function, body weight or appetite, sleep (e.g: domperidone and cisapride, anticholinergic drugs (e.g.: atropine), metoclopramide, orlistat, thyroid medications, diuretics, glucocorticoids, sex steroids, metformin, dipeptidyl peptidase-IV inhibitors, melatonin) * recent weight change in past 3 months (\> 5% current body weight) * individuals who regularly perform high intensity exercise (\>2 week) * current intake of \> 140g alcohol/week * current smokers of cigarettes/cigars/marijuana/e-cigarettes/vaporisers * current intake of any illicit substance * unable to comprehend study protocol * currently performing shift work * has undertaken, or is planning to undertake, trans meridian travel during the study period, or the preceding 60 days * do not own a smartphone * eats for less than a 12-hour period per day
Healthy Volunteers: True
Sex: MALE
Minimum Age: 40 Years
Maximum Age: 70 Years
Study: NCT03590158
Study Brief:
Protocol Section: NCT03590158